Skip to main content
. 2021 Jul 22;194(4):690–700. doi: 10.1111/bjh.17527

Fig 1.

Fig 1

Toxicity management in ZUMA‐1. *Only in case of comorbidities or older age. †Only if no improvement with tocilizumab, use standard dose. ‡If no improvement after 24 h. §If no improvement after three days. ||Only for grade 2 or higher NEs with concurrent CRS. AE, adverse event; CRS, cytokine release syndrome; HD, high dose; Mgmt, management; NE, neurologic event. [Colour figure can be viewed at wileyonlinelibrary.com]